Back to Top Skip to main content Skip to sub-navigation

DoD launches effort to collect COVID-19 convalescent plasma

Image of man wearing mask and giving blood Donald Perry, a Fort Bragg civilian employee, recently recovered from COVID-19 and donated his plasma at the Fort Bragg Blood Donor Center May 7. (Photo by Twana Atkinson)

Recommended Content:

Coronavirus

Patients who have recovered from COVID-19 may hold treatment in their veins that could help others who are critically ill with the respiratory infection.

The Department of Defense has begun an effort to collect 8,000 donated units of plasma from patients who have recovered from COVID-19 to support the development of an effective treatment against the disease.

“We may want to ask you to stick your arm out and donate blood,” Joint Chiefs of Staff Chairman Gen. Mark Milley said in a May 28 virtual town hall. “What that can then do is help others who are severely ill, and if we can do that, then we’ll be on a good path toward getting some really powerful therapeutics.”

Donations will be accepted at 15 Armed Services Blood Program centers across the continental United States, and in Hawaii, Guam and Germany. (A complete list of centers accepting donations appears at the end of this article, and is available online.)

Patients fully recovered from COVID-19 are the only ones who qualify to be a COVID-19 convalescent plasma donor, said Army Col. Audra Taylor, chief of the Armed Services Blood Program. DOD personnel and their families, as well as non-DOD civilians with access to collection facilities on installations, are welcome to donate.

"Our goal as a lifesaving program is to always provide a safe and ample supply of blood products. The need is now,” Taylor stressed. “We are calling for all who are healthy, able, and eligible, to donate today to help us all stand mission ready and save lives."

Why convalescent plasma is collected

When a person contracts SARS-CoV-2, the virus that causes COVID-19, their immune systems create antibodies to fight the virus. These antibodies are found in the plasma—the liquid part of blood, Taylor explained.

Plasma with infection-fighting antibodies is called convalescent plasma, she said. Through the blood donation process, this plasma is collected from a donor who has recovered from COVID-19 and may be transfused into a sick patient who is still fighting the virus, if they qualify for this type of treatment. The procedure may boost the immune system of the patient and help with the recovery process, Taylor said.

The collection process for this type of plasma is the same as standard apheresis collection, she noted. It is being investigated for the treatment of COVID-19 because there is no approved treatment for the disease at this time, and there is some indication that it might help some patients recover from COVID-19.

Several COVID-19 patients in the Military Health System have received convalescent plasma transfusions as part of their treatment, Taylor said. The treatment, which must be carried out under an approved protocol, is used for those hospitalized and severely ill with the disease.

Eligibility requirements

Donating CCP is the same as a standard platelet or plasma donation and must meet specific requirements set by the Food and Drug Administration. Donors must be at least 17 years and older, weigh at least 110 pounds, and be in good health. Women who have ever been pregnant may need additional testing for specific human leukocyte antigen antibodies that may be present in their blood. In addition to these standard requirements, those who have fully recovered from COVID-19 must be symptom-free for at least 14 days. Donors must also produce documented laboratory test results proving they tested positive for the virus, Taylor explained.

“If a donor believes they meet these requirements, they must first contact the local blood donor center before coming in, and if they qualify, set up an appointment,” said Army Col. Jason Corley, Army Blood Program director. “Once set up, the donor must bring the required documentation and undergo the standard donation procedure. Final determination will be made by the medical director or designee.”


ASBP Centers Collecting Convalescent Plasma

— Armed Services Blood Bank Center, Walter Reed National Military Medical Center, Bethesda, Maryland

— Naval Medical Center Portsmouth Blood Donor Center, Portsmouth, Virginia

— Fort Bragg Blood Donor Center, Fort Bragg, North Carolina

— Kendrick Memorial Blood Center, Fort Gordon, Georgia

— Sullivan Memorial Blood Center, Fort Benning, Georgia

— Blood Donor Center, Keesler Air Force Base, Mississippi

— Lackland Air Force Base Armed Services Blood Bank Center, Joint Base San Antonio-Lackland, Texas

— Robertson Blood Center, Fort Hood, Texas

— Akeroyd Blood Donor Center, Fort Sam Houston, Texas

— Fort Bliss Blood Donor Center, Fort Bliss, Texas

— Naval Medical Center San Diego Blood Donor Center, San Diego, California

— Armed Services Blood Bank Center – Pacific Northwest, Joint Base Lewis-McChord, Washington

— Tripler AMC Blood Donor Center, Tripler Army Medical Center, Hawaii

— Naval Hospital Blood Donor Center, Guam

— Armed Services Blood Bank Center Europe, Landstuhl Regional Medical Center, Germany

Links to More Information

Armed Services Blood Program

ASBP COVID-19-specific page

Blood Drive and Donor Registration

— Facebook: militaryblood 

— Twitter: @militaryblood 

— Instagram: @usmilitaryblood

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.